inherited acute myeloid leukemia
ORPHA: 3194652 Treatments Available
Overview
instance of acute myeloid leukemia that is caused by an inherited modification of the individual's genome
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| cytarabine Cold Chain | IV infusion, 20mg/mL, 100mg/mL; Intrathecal injection, 50mg/mL | FDA Approved, EMA Approved | 10 | 3d |
| imatinib mesylate Orphan | Oral tablet, 100mg, 400mg | FDA Approved, EMA Approved | 9 | 7d |
Classification & Codes
Orphanet Code
ORPHA:319465inherited acute myeloid leukemia
| Orphanet | ORPHA:319465 |
| Treatments | 2 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO